Kailera Therapeutics, Inc. (KLRA)
10.82
-0.51
(-4.50%)
USD |
NASDAQ |
Oct 13, 14:03
Kailera Therapeutics Shareholders Equity (Quarterly) : 1.118B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.118B |
| Date | Value |
|---|---|
| March 31, 2026 | 560.28M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Twist Bioscience Corp. | 445.74M |
| Prime Medicine, Inc. | 39.81M |
| GRAIL, Inc. | 2.543B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.211B |
| Total Liabilities (Quarterly) | 92.95M |
| Debt to Equity Ratio | 0.0091 |
| Current Ratio | 11.11 |